Okyo Pharma (OKYO) news

Okyo Pharma: Chairman Gabrielle Cerrone increased holdings in company, bringing total holding to 20.55% of issued share capital

Gabrielle Cerrone, Chairman of Okyo Pharma, has increased her stake in the company, raising her total ownership to 20.55% of the issued share capital[1]. This move reflects a significant personal investment in the company’s future and aligns with Cerrone’s long-term commitment to Okyo Pharma’s…

Okyo Pharma - FDA agrees to single-dose Phase 3 study design and potential single-trial registration for urcosimod

Okyo Pharma reports positive feedback from FDA Type D meeting and accelerates Urcosimod into global Phase 3 pivotal trial for neuropathic corneal pain

Okyo Pharma Ltd: Okyo expands scientific advisory board with appointment of intl expert Marta Sacchetti, MD, PhD

OKYO Pharma Ltd (NASDAQ:OKYO) has expanded its Scientific Advisory Board with the appointment of Marta Sacchetti, MD, PhD, an internationally recognized expert in ophthalmology and ocular immunology. Dr. Sacchetti brings extensive academic, clinical, and industry experience to the company, having…

Tokyo Metro plans to launch hotel business: Nikkei

Tokyo Metro plans to launch hotel business: Nikkei Tokyo Metro, a key player in Japan's public transportation landscape, is set to expand its operations into the hospitality sector. The company has announced plans to launch a hotel business, a move that reflects its strategic pivot to diversify…